In a trailblazing advancement in cancer therapy, researchers at Korea Advanced Institute of Science and Technology (KAIST) have developed a technology that transforms colon cancer cells into ...

Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.

Researchers identify stem cell–based molecular subtypes that improve prognosis prediction in colorectal cancer and support ...

Polish scientists have developed and tested a chemical compound that shows strong activity against colorectal cancer cells ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of cancer-related death worldwide. One critical factor that makes treating colon ...

Five years ago, Tim Cannon, a cancer doctor in Virginia, saw that his colon cancer patients were getting younger and their ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

Circulating tumor cells (CTCs) have been detected in patients with a variety of solid tumors and may be predictive of prognosis. Although the US Food and Drug Administration has approved some methods ...

The American Cancer Society recommends that people at average risk of colorectal cancer start regular screening at age 45, and several blood tests on the market could help. These tests are done in a ...